2023 

Acheinu Cancer Support Reg. Charity Number:1181606 







ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 





## ACHEINU CANCER SUPPORT 

## LEGAL AND ADMINISTRATIVE INFORMATION 

**Trustees** Mr Morris Herzog Mr Moshe Hersh Kahan Mrs C G Werthaim Mrs C R Wosner **Charity number** 1181606 

**Registered office** 99 - 101 Dunsmure Road London N16 5HT **Independent examiner** Mr J Silver FCCA Precision Ltd 32 Castlewood Road London N16 6DW **Bankers** Lloyds Bank PLC Lewisham London SE13 6JG 






## ACHEINU CANCER SUPPORT 

## CONTENTS 

||**Page**|
|---|---|
|Trustees' report|1 - 5|
|Independent examiner's report|6|
|Statement of financial activities|7|
|Balance sheet|8|
|Statement of cash flows|9|
|Notes to the financial statements|10- 18|







## ACHEINU CANCER SUPPORT 

## TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 

The trustees present their report and financial statements for the year ended 31 December 2023. 

The financial statements have been prepared in accordance with the accounting policies set out in note 1 to the financial statements and comply with the charity's governing document, the Charities Act 2011 and "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). 

## **Our mission** 

To ease the burden of a cancer diagnosis by providing a range of medical, practical and wellbeing support to patients and their families, helping them through the journey to recovery and remission 

## **Charitable objectives** 

The relief of sickness and the preservation and protection of good health for the public benefit among people and their families/carers who are suffering from, have suffered in the past, or living with a diagnosis of cancer, by providing and assisting in the provision of treatment, facilities, practical and emotional support, and guidance through appropriate referrals and signposting to enable such people to receive immediate help and support if not otherwise readily available due to lack of financial means. 

## **Achievements and performance:** 

ACS has continued to see an increase in demand for our services, with a staggering number of outreach calls from those seeking support. 

ACS provided 93 cancer patients with a wide variety of support services, with the total number of close family members benefiting from support services being over 400. Additionally, our awareness project has impacted a vast number of several hundred people from the wider community. 

During the year we have provided a wide range of support services, including: 

**Medical Support** - When cancer strikes, time is of essence. Accessing the right medical intervention quickly is often the key to a hopeful prognosis. That is where ACS comes in – tirelessly advocating for targeted medical care. 

## We provide: 

Hospital Intermediaries: When patients – understandably – struggle to gather their wits and are unable to focus on technicalities, ACS will often adopt the role of intermediary. 

Signposting and Referrals: Patients turn to ACS with concerns or soon after receiving a cancer diagnosis. Our team offers guidance, support and hand-holding as they embark on the cancer treatment journey. ACS medical support workers assist patients with the booking of appointments, referrals, and seeking a second opinion, where appropriate. 

Complimentary Therapy: ACS understands that health involves more than just the body. It is currently an accepted belief that complementary therapies help patients cope with the stress of cancer and its treatments. We support patients who are seeking to pursue alternative therapies such as; acupuncture, massage, reflexology or specific dietary needs. 

Community awareness: in conjunction with the NHS NEL Cancer Alliance ACS has launched a 2-year project to increase cancer awareness in the community. Through community events, targeted advertisements, leaflets and wellness checks we are raising awareness in the community and improving the number of people who are receiving medical intervention at an earlier stage. 

**Practical Support** - Logistics can be overwhelming for anyone – especially for those with a cancer-diagnosis hanging. ACS takes care of the nitty-gritty details so that patients are free to focus on the most important thing; their health and recovery. 

- 1 - 





## ACHEINU CANCER SUPPORT 

## TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 

## We provide: 

Transport: Where possible, ACS coordinates volunteers to drive and accompany patients to appointments, who are on hand to advocate and provide comfort. When volunteers are not available, ACS provides paid taxi transportation for patients with low immunity who are too weak to use public transportation. 

Cooked Meals: Healthful, cooked meals from local delicatessens are sent to hospital patients eager for a taste of home. Meals are delivered to the family back home as well, who are often left without supper whilst their parents are occupied in hospital corridors. Additionally, visiting support workers make sure to drop off small treats and snacks, providing sweet encouragement. 

Grocery Deliveries: Patients' families receive grocery essentials to their door. With the growing inflation and reduced income whilst sick, patients and families depend on these deliveries to make it through the weeks and months. 

Lunch Brunch: To assist families during times of crisis we have launched a new project, involving a team of dedicated volunteers who pack and deliver nutritious school lunches and snacks on a daily basis. This service enables children whose parents are consumed by the cancer diagnosis to feel nurtured and cared for, and attend school with an improved state of mind. 

Financial support: An ACS office staff member supports users in accessing the benefits and allowances they are entitled to, and also support them in attaining individual grants where appropriate. 

Care Packages: For an extra touch of care, we offer individual care packages to suit the needs of the patient and family. These packages include games, toys, special magazines and pampering sets, providing hope and healing to those in need. 

**Wellbeing Support** - A cancer prognosis affects the mental wellbeing of patients and their families. In a big way. ACS recognizes that it is not only medical and practical support that's needed-they need emotional support to. 

## We provide: 

Day Trips and holiday clubs: Between numerous appointments family time can get lost. ACS presents families of patients with all expenses-paid thrilling day out, winging them off to exhilarating locations like Adventure Island or KidZania. For children who have had their entire home life erupt into chaos, such trips are game changing. Additionally, we also provide clubs during holiday seasons. 

Respite: Families are treated with a countryside holiday on an annual basis. The time away helps them refresh and regroup, so that they can face their daily hurdles. 

Communal Retreat: once again, ACS hosted a weekend retreat for adults affected by cancer. Whether they themselves, their spouse or a child was suffering from cancer, ACS welcomed people from across the UK for an unforgettable weekend away. 

Support Groups: Support groups for adults and children of varying ages are led by experienced and caring professionals where patients and their families have the opportunity to openly share their struggles and gain courage from each other. 

Therapy: ACS extends its care by assisting family members in need of psychotherapy due to the painful circumstances. Costs for sessions, supervision and supplies are covered. 

Toys and Games: ACS brightens young lives with exciting care packages of gifts and vouchers delivered on holidays, birthdays and at times when the situation is especially bleak. 

**Post-Cancer Support -** Cancer does have an endpoint, somewhere. But these battle-weary heroes need our continued support and understanding to get their lives back on track. ACS will continue supporting patients and their families for as long as they need to heal and move on. 

We provide: 

Wellbeing sessions: Where necessary, ACS will continue covering costs for ongoing massage, physiotherapy and other complimentary sessions, as much as the patient reasonably needs to recover and get back to themselves. 

- 2 - 





## ACHEINU CANCER SUPPORT 

## TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 

Bereavement Support: ACS will continue supporting bereaved family members with individual therapies for a time, to enable them to heal and move on. 

Practical Support: Despite families having moved on from the active cancer stage, ACS ensures not to leave patients and their families high and dry; day trips, meals and whatever else is needed will keep being provided for a while. 

## **Financial review:** 

Over the previous year there has been an increase in the donations received of over 30%. Our level of free reserves has increased to £107,704 (2022: £31,596). 

The trustees are satisfied with the results, significant progress has been made in meeting the charity's reserves policy as stated below. The trustees will further increase the charity's fundraising efforts to ensure that going forward the charity will meet their target of retaining three months running costs in reserves ensuring financial stability for the organization. 

In addition, the charity has Restricted funds of £43,024 to carry out various specific projects. 

Looking ahead, we continue to remain confident in our charity to raise funds from the community as well as from grant giving charities. We also plan to broaden our fundraising base by accessing statutory funding from local authorities and acting on market research that we have undertaken locally. 

It is the policy of the charity that unrestricted funds which have not been designated for a specific use should be maintained at a level equivalent to three month’s expenditure. The trustees consider that reserves at this level will ensure that, in the event of a significant drop in funding, they will be able to continue the charity’s current activities while consideration is given to ways in which additional funds may be raised. 

The trustees have assessed the major risks to which the charity is exposed, and are satisfied that systems are in place to mitigate exposure to the major risks. All financial transactions and payments are authorized by two unrelated payment authorizes. 

## **Plans for the future:** 

Monitoring system: In order to gain a better understanding of how well different projects and services have benefitted those in need and how to improve services, trustees have approved the purchase of a new monitoring system from Salesforce. The new system was introduced at the end of 2023, with the intention of all staff training and adopting the system in 2024. 

Community Awareness:  After successfully launching the awareness project in march 2023 in conjunction with the NHS Cancer Alliance, we are excited to continue the project throughout 2024. 

Networking: ACS will continue contacting professionals and specialists to better be equipped in signposting our users. 

## **Patient testimonials:** 

- _I just want to thank you so much for the beautiful books you sent!!! I was sad to tear the wrapping paper, I could sense it was wrapped with such warmth and care. It came into good use and really enhanced my hospital stay._ 

- _I wanted to thank you for the support group. Because I’m not anymore on treatments, the side effects and after effects of the illness is much worse than the illness alone. And when you arrive to the support group you don’t feel alone and you know that it’s not you, it’s the illness that’s made it. The support group gave me loads and loads of strength to go further. So, thanks again._ 

- _This Lunch Brunch is a blessing in disguise, being that my wife is so weak it takes a huge pressure off me. In the morning, I just give each child his or her bag. You have no idea what a great help this is._ 

## **Feedback from professionals:** 

## Dr Rachel Hines - GP and Menopause Specialist 

_It was lovely to meet you last night. Thanks so much for inviting me, and making me feel so welcome. I really enjoyed it and hope it was helpful. There were so many questions which was amazing, I’m happy so many people felt comfortable to ask on the night._ 


- 3 - 





## ACHEINU CANCER SUPPORT 

## TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 

## Mr Ranjeev Bhangoo, Neurosurgeon, FRCS (ENG) FRCS (SN) 

_I have always found ACS to be a very strong patient advocate who go the extra mile to personalize patient care and ensure that patients and their families are able to not only get the best treatment for themselves but also the information that they need in order to be able to make an informed decision which is such an important part of their journey._ 

## Dr Ali Rismani MBBS MRCP FRCPath, Haematologist 

_ACS cancer provides an unbelievable professional service for their members and the community it serves. They are compassionate with an incredibly positive attitude even in very difficult circumstances. Their endless enthusiasm has helped overcome many difficult situations for their community. Honestly, I can’t praise them enough and they are a great example for other similar organisations to follow._ 

## Caroline Cook, Early Diagnosis Programme Lead, NEL Cancer Alliance 

_Funding Acheinu Cancer Support (ACS) to raise awareness of cancer symptoms in the Charedi community has been a really worthwhile experience for the North East London Cancer Alliance. Their expertise as a trusted community organisation means they have been able to reach people that we, as an NHS organisation, cannot. ACS have delivered over and above our expectations and are doing great work to increase earlier diagnosis of cancer and improve outcomes for the Charedi community in NEL. We have truly valued this opportunity to work in partnership on our shared goals._ 

## **Acknowledgements:** 

ACS is deeply grateful to those individuals, charities, and trusts who partner with us, enabling us to continue our vital work of supporting those affected by cancer. 

Community donations: we are eternally grateful to the hundreds of individuals who have generously pledged donations ahead of our January 2024 gala dinner. We have successfully raised pledged donations of over £1,000,000 which will be donated over the next two years. 

Charities, Foundations and Trusts:  we extend our heartfelt gratitude to those who have generously supported ACS. Your unwavering support has been instrumental in our mission to provide crucial assistance to cancer patients. We remain deeply appreciative for your invaluable contributions. 

Some of these are: M&P Leadale Group LTD, Amabrill ltd, Triplerose Ltd, MG GR Ltd, Jaylow Supplies Ltd, Anton Jurgens, Hackney Giving, Big Give, Julias and Hans Rausing Trust, NHS Cancer Alliance, City Bridge Foundation, The Gerald Ronson Foundation, Delapage, BBC Children in Need, James Tudor Foundation, B M Shemtob Charitable Trust, Acconia Industrial, Merchant Taylor Foundation, The Irving Memorial Trust, Joan Wilkinson Charitable Trust, The Hilary Awdry Charitable Trust and many others. 

## **Structures, governance and management** 

The charity is a Charitable Incorporated Organization and is controlled by its governing document dated 01 August 2018 and as amended on the 20 January 2022, which includes the objects of the charity. It was registered as a charity on the 17 January 2019. 

The trustees who served during the year and up to the date of signature of the financial statements were: Mr Morris Herzog Mr Moshe Hersh Kahan Mrs C G Werthaim Mrs C R Wosner 

ACS have developed policies and procedures that reflect our organisational values. We are committed to maintaining high ethical standards such as safeguarding the welfare of all our employees and volunteers and everyone who receives our support. We believe all children and adults have the right to protection from all types of harm or abuse. Our employees and volunteers have a duty to prevent the abuse of children and adults and report any safeguarding concerns to the relevant person. We support and train our people and monitor performance in such areas as safeguarding, health and safety, information security and data protection. 

- 4 - 





## ACHEINU CANCER SUPPORT 

## TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023 

ACS services are provided to all without discrimination. We value gender equality; and neurodiversity. We value differences in employees, volunteers, professionals, people living with cancer and supporters, and understand and respond to their different needs and situations. 

Day-to-day management of activities is carried out by the Director, supported by a Projects Coordinator, Finance Manager and administrative support. 

ACS's patient coordinators are under continuous supervision, adhering to full training relevant to their posts. Activities are supervised and run by our Project Coordinator, 14 part-time employees, as well as a team of dedicated volunteers. 

The Trust Deed requires that the number of Trustees shall not be less than three, and no more than seven. The power to appoint new Trustees is vested in the existing Trustees. It is not currently the intention of the charity to appoint new trustees. However, shall the situation change in the future new Trustees will be recruited for their competence, specialist skills and ability to promote the objectives of the Charity. New Trustees are appointed by the resolution of the Trustees, which is recorded in the minutes and signed by a Trustee, and are given induction and appropriate training by the current Trustees. 

The Board and its committees meet minimum four times a year. The Board has delegated specific responsibilities to its committees, each of which has detailed terms of reference and reports to the Board. The remit of the committees is reviewed regularly to ensure they continue to work well. 

If the charity is wound up or upon dissolution the remaining assets must be distributed to not-for-profit organisations as detailed in the constitution. 

None of the trustees has any beneficial interest in the charity. 

The trustees' report was approved by the Board of Trustees. 


**----- Start of picture text -----**<br>
--------------<br>**----- End of picture text -----**<br>


-------------- **Mr Moshe Hersh Kahan** Trustee Dated: 09/09/2024 

- 5 - 





## ACHEINU CANCER SUPPORT 

## INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF ACHEINU CANCER SUPPORT 

I report to the trustees on my examination of the financial statements of Acheinu Cancer Support (the charity) for the year ended 31 December 2023. 

## **Responsibilities and basis of report** 

As the trustees of the charity, you are responsible for the preparation of the financial statements in accordance with the requirements of the Charities Act 2011 (the 2011 Act). 

I report in respect of my examination of the charity’s financial statements carried out under section 145 of the 2011 Act. In carrying out my examination I have followed all the applicable Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act. 

## **Independent examiner's statement** 

Since the charity’s gross income exceeded £250,000 your examiner must be a member of a body listed in section 145 of the 2011 Act. I confirm that I am qualified to undertake the examination because I am a member of ACCA, which is one of the listed bodies. 

Your attention is drawn to the fact that the charity has prepared financial statements in accordance with Accounting and Reporting by Charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) in preference to the Accounting and Reporting by Charities: Statement of Recommended Practice issued on 1 April 2005 which is referred to in the extant regulations but has now been withdrawn. 

I understand that this has been done in order for financial statements to provide a true and fair view in accordance with Generally Accepted Accounting Practice effective for reporting periods beginning on or after 1 January 2015. 

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe that in any material respect: 

- 1 accounting records were not kept in respect of the charity as required by section 130 of the 2011 Act; or 

- 2 the financial statements do not accord with those records; or 

- 3 the financial statements do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination. 

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the financial statements to be reached. 


**J Silver FCCA Precision Ltd 32 Castlewood Road N16 6DW** 

Dated: ......................... 

- 6 - 





## ACHEINU CANCER SUPPORT 

## STATEMENT OF FINANCIAL ACTIVITIES INCLUDING INCOME AND EXPENDITURE ACCOUNT FOR THE YEAR ENDED 31 DECEMBER 2023 

|**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2023**<br>**2023**<br>**Notes**<br>**£**<br>**£**<br>**Income from:**<br>Donations and<br>legacies<br>**3**<br>677,480<br>-<br>Charitable activities<br>**4**<br>-<br>143,856<br>Investments<br>**5**<br>-<br>-<br>Gross transfers<br>between funds<br>677,480<br>143,856<br>**Expenditure on:**<br>Raising funds<br>**6**<br>77,190<br>-<br>Charitable activities<br>**7**<br>494,406<br>213,269<br>**Total expenditure**<br>571,596<br>213,269<br>**Net incoming/(outgoing)**<br>**resources before**<br>**transfers**<br>**Net movement in funds**<br>105,884<br>(69,413)<br>Fund balances at 1 January<br>2023<br>(29,776)<br>29,776<br>**Fund balances at 31**<br>**December 2023**<br>107,704<br>43,024<br>76,108<br>(39,637)<br>31,596<br>82,661<br>Net income/(expenditure)<br>For the year/|**Total**<br>**Unrestricted**<br>**Restricted**<br>**funds**<br>**funds**<br>**2023**<br>**2022**<br>**2022**<br>**£**<br>**£**<br>**£**<br>677,480<br>463,191<br>-<br>143,856<br>-<br>150,906<br>-<br>5,128<br>-<br>821,336<br>468,319<br>150,906<br>77,190<br>58,328<br>-<br>707,675<br>538,398<br>106,326<br>784,865<br>596,726<br>106,326<br>36,471<br>(128,407)<br>44,580<br>-<br>-<br>-<br>150,728<br>31,596<br>82,661<br>36,471<br>(128,407)<br>44,580<br>114,257<br>160,003<br>38,081|**Total**<br>**2022**<br>**£**<br>463,191<br>150,906<br>5,128<br>619,225<br>58,328<br>644,724<br>703,052<br>(83,827)<br>-<br>114,257<br>(83,827)<br>198,084|**Total**<br>**2022**<br>**£**<br>463,191<br>150,906<br>5,128<br>619,225<br>58,328<br>644,724<br>703,052<br>(83,827)<br>-<br>114,257<br>(83,827)<br>198,084|
|---|---|---|---|
|||||
|||||
||||114,257|



The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities. 

- 7 - 





## ACHEINU CANCER SUPPORT 

## BALANCE SHEET AS AT 31 DECEMBER 2023 

|**Notes**<br>**Fixed assets**<br>Tangible assets<br>**13**<br>**Current assets**<br>Debtors<br>**14**<br>Cash at bank and in hand<br>**Creditors: amounts falling due within**<br>**one year**<br>**16**<br>Net current assets<br>**Total assets less current liabilities**<br>**Creditors: amounts falling due after**<br>**more than one year**<br>**17**<br>**Net assets**<br>**Income funds**<br>Restricted funds<br>Unrestricted funds|**2023**<br>**£**<br>-<br>184,511<br>184,511<br>(16,346)|**£**<br>9,647<br>168,165<br>177,812<br>(27,084)<br>150,728<br>43,024<br>107,704<br>150,728|**2022**<br>**£**<br>2,500<br>150,917<br>153,417<br>(18,445)|**£**<br>11,369<br>134,972<br>146,341<br>(32,084)<br>114,257<br>82,661<br>31,596<br>114,257|
|---|---|---|---|---|



The financial statements were approved by the Trustees on 09/09/2024 


.............................. Mr Moshe Hersh Kahan **Trustee** 

- 8 - 





## ACHEINU CANCER SUPPORT 

## STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2023 

|**Notes**<br>**Cash flows from operating activities**<br>Cash generated from/(absorbed by)<br>operations<br>**20**<br>**Investing activities**<br>Investment income received<br>**Net cash (used in)/generated from**<br>**investing activities**<br>**Financing activities**<br>Repayment of bank loans<br>**Net cash used in financing activities**<br>**Net increase/(decrease) in cash and cash**<br>**equivalents**<br>Cash and cash equivalents at beginning of year<br>**Cash and cash equivalents at end of year**|**2023**<br>**£**<br>-<br>(5,000)|**£**<br>38,594<br>-<br>(5,000)<br>33,594<br>150,917<br>184,511|**2022**<br>**£**<br>5,128<br>(4,999)|**£**<br>(8,224)<br>5,128<br>(4,999)<br>(8,095)<br>159,012<br>150,917|
|---|---|---|---|---|



- 9 - 





## ACHEINU CANCER SUPPORT 

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **1 Accounting policies** 

## **Charity information** 

Acheinu Cancer Support is a public benefit entity and a Charitable Incorporated Organisation registered in England and Wales. 

## **1.1 Accounting convention** 

The financial statements have been prepared in accordance with the charity's governing document,  the Charities Act 2011, FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the Charities SORP "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019). The charity is a Public Benefit Entity as defined by FRS 102. 

The financial statements have departed from the Charities (Accounts and Reports) Regulations 2008 only to the extent required to provide a true and fair view. This departure has involved following the Statement of Recommended Practice for charities applying FRS 102 rather than the version of the Statement of Recommended Practice which is referred to in the Regulations but which has since been withdrawn. 

The financial statements are prepared in sterling, which is the functional currency of the charity. Monetary amounts in these financial statements are rounded to the nearest £. 

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below. 

## **1.2 Going concern** 

At the time of approving the financial statements, the trustees have a reasonable expectation that the charity has adequate resources to continue in operational existence for the foreseeable future, based on the continued support from the community. Thus the trustees continue to adopt the going concern basis of accounting in preparing the financial statements. 

## **1.3 Charitable funds** 

Unrestricted funds are available for use at the discretion of the trustees in furtherance of their charitable objectives. 

Restricted funds are subject to specific conditions by donors as to how they may be used. The purposes and uses of the restricted funds are set out in the notes to the financial statements. 

Endowment funds are subject to specific conditions by donors that the capital must be maintained by the charity. 

## **1.4 Income** 

Income is recognised when the charity is legally entitled to it after any performance conditions have been met, the amounts can be measured reliably, and it is probable that income will be received. 

Cash donations are recognised on receipt. Other donations are recognised once the charity has been notified of the donation, unless performance conditions require deferral of the amount. 

Legacies are recognised on receipt or otherwise if the charity has been notified of an impending distribution, the amount is known, and receipt is expected. If the amount is not known, the legacy is treated as a contingent asset. 

- 10 - 





## ACHEINU CANCER SUPPORT 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **(Continued)** 

## **1 Accounting policies** 

## **1.5 Expenditure** 

Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates: 

Expenditure on charitable activities includes all costs incurred by a charity in undertaking activities that further its charitable aims for the benefit of its beneficiaries, including those support costs and costs relating to the governance of the charity apportioned to charitable activities. 

## **1.6 Tangible fixed assets** 

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses. 

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases: 

Fixtures and fittings 25% RBM Computers 15% RBM 

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the statement of financial activities. 

## **1.7 Impairment of fixed assets** 

At each reporting end date, the charity reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). 

## **1.8 Cash and cash equivalents** 

Cash and cash equivalents include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities. 

## **1.9 Financial instruments** 

The charity has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments. 

Financial instruments are recognised in the charity's balance sheet when the charity becomes party to the contractual provisions of the instrument. 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously. 

## _**Basic financial assets**_ 

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised. 

- 11 - 





## ACHEINU CANCER SUPPORT 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **(Continued)** 

## **1 Accounting policies** 

## _**Basic financial liabilities**_ 

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised. 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method. 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of operations from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method. 

## _**Derecognition of financial liabilities**_ 

Financial liabilities are derecognised when the charity’s contractual obligations expire or are discharged or cancelled. 

## **1.10 Employee benefits** 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received. 

Termination benefits are recognised immediately as an expense when the charity is demonstrably committed to terminate the employment of an employee or to provide termination benefits. 

## **1.11 Retirement benefits** 

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due. 

## **2 Critical accounting estimates and judgements** 

The preparation of the financial statements did not require management to make judgements, estimates or assumptions that affect the amounts reported. 

## **3 Donations and legacies** 

||**Unrestricted **|**Unrestricted**|
|---|---|---|
||**funds**|**funds**|
||**2023**|**2022**|
||**£**|**£**|
|Donations and gifts|677,480|454,191|
|Grant Income|-|9,000|
||677,480|463,191|



- 12 - 





## ACHEINU CANCER SUPPORT 

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **4 Charitable activities** 

|**5**<br>**6**|**Charitable**<br>**Income**<br>**Charitable**<br>**Income**<br>**2023**<br>**2022**<br>**£**<br>**£**<br>Performance related grants<br>143,856<br>150,906<br>**Investments**<br>**Total Unrestricted**<br>**funds**<br>**2023**<br>**2022**<br>**£**<br>**£**<br>Interest receivable<br>-<br>5,128<br>**Raising funds**<br>**Unrestricted Unrestricted**<br>**funds**<br>**funds**<br>**2023**<br>**2022**<br>**£**<br>**£**<br>Fundraising and publicity<br>Staging fundraising events<br>71,693<br>40,000<br>Advertising<br>4,718<br>17,128<br>Other fundraising costs<br>779<br>1,200<br>Fundraising and publicity<br>77,190<br>58,328<br>77,190<br>58,328|
|---|---|



- 13 - 





## ACHEINU CANCER SUPPORT 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **7 Charitable activities** 

|Staff costs<br>Depreciation and impairment<br>Charitable Expenditure<br>Grant funding of activities (see note 8)<br>Share of support costs (see note 9)<br>Share of governance costs (see note 9)<br>**Analysis by fund**<br>Unrestricted funds<br>Restricted funds|**Medical**<br>**Care**<br>**Wellbeing**<br>**support**<br>**Practical**<br>**support**<br>**2023**<br>**2023**<br>**2023**<br>**£**<br>**£**<br>**£**<br>14,220<br>26,401<br>23,036<br>378<br>760<br>584<br>103,578<br>214,162<br>162,447<br>118,176<br>241,323<br>186,067<br>305<br>-<br>-<br>31,446<br>63,135<br>48,499<br>4,115<br>8,262<br>6,347<br>154,042<br>312,720<br>240,913<br>109,852<br>198,079<br>186,475<br>44,190<br>114,641<br>54,438<br>154,042<br>312,720<br>240,913|**Total**<br>**2023**<br>**£**<br>63,657<br>1,722<br>480,187<br>545,566<br>305<br>143,080<br>18,724<br>707,675<br>494,406<br>213,269<br>707,675|**Medical**<br>**Care**<br>**Wellbeing**<br>**support**<br>**Practical**<br>**support**<br>**2022**<br>**2022**<br>**2022**<br>**£**<br>**£**<br>**£**<br>7,781<br>30,687<br>9,117<br>434<br>758<br>841<br>102,711<br>182,101<br>205,115<br>110,926<br>213,546<br>215,073<br>-<br>-<br>-<br>19,168<br>33,745<br>37,164<br>3,223<br>5,631<br>6,248<br>133,317<br>252,922<br>258,485<br>132,316<br>179,068<br>227,014<br>1,001<br>73,854<br>31,471<br>133,317<br>252,922<br>258,485|**Total**<br>**2022**<br>**£**<br>47,585<br>2,033<br>489,927<br>539,545<br>-<br>90,077<br>15,102<br>644,724<br>538,398<br>106,326<br>644,724|
|---|---|---|---|---|



- 14 - 





## ACHEINU CANCER SUPPORT 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **8 Grants payable** 

|Grants to institutions:<br>**Support costs**<br>Staff costs<br>Office rent<br>General office expenses<br>IT Services<br>Advertising<br>Accountancy<br>Legal and professional<br>Bank Charges & Other<br>fees<br>Bank loan interest|**Support**<br>**costs**<br>**Governance**<br>**costs**<br>**£**<br>**£**<br>53,641<br>-<br>22,440<br>-<br>32,402<br>-<br>4,964<br>-<br>29,633<br>-<br>-<br>4,920<br>-<br>1,023<br>-<br>11,906<br>-<br>875<br>143,080<br>18,724|**2023**<br>**£**<br>53,641<br>22,440<br>32,402<br>4,964<br>29,633<br>4,920<br>1,023<br>11,906<br>875<br>161,804|**Medical Care**<br>**2023**<br>**£**<br>305<br>**Support**<br>**costs**<br>**Governance**<br>**costs**<br>**£**<br>**£**<br>34,643<br>-<br>22,880<br>-<br>16,683<br>-<br>4,293<br>-<br>11,578<br>-<br>-<br>5,100<br>-<br>1,911<br>-<br>7,097<br>-<br>994<br>90,077<br>15,102|2022<br>£<br>-|
|---|---|---|---|---|
|||||**2022**<br>**£**<br>34,643<br>22,880<br>16,683<br>4,293<br>11,578<br>5,100<br>1,911<br>7,097<br>994|
|||||105,179|



## **9 Support costs** 

## **10 Trustees** 

None of the trustees (or any persons connected with them) received any remuneration or benefits from the charity during the year. 

## **11 Employees** 

The average monthly number of employees during the year was: 

|**2023**|**2022**|
|---|---|
|**Number**|**Number**|
|14|9|



- 15 - 





## ACHEINU CANCER SUPPORT 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

|**11**<br>**Employees**<br>**Employment costs**<br>Wages and salaries<br>Other pension costs|**(Continued)**<br>**2023**<br>**2022**<br>**£**<br>**£**<br>116,724<br>86,137<br>574<br>-<br>117,298<br>86,137|**(Continued)**<br>**2023**<br>**2022**<br>**£**<br>**£**<br>116,724<br>86,137<br>574<br>-<br>117,298<br>86,137|
|---|---|---|
|||86,137|



There were no employees whose annual remuneration was more than £60,000. 

## **12 Taxation** 

The charity is exempt from tax on income and gains falling within section 505 of the Taxes Act 1988 or section 252 of the Taxation of Chargeable Gains Act 1992 to the extent that these are applied to its charitable objects. 

## **13 Tangible fixed assets** 

|**Tangible fixed assets**||
|---|---|
|**Fixtures and**<br>**fittings**<br>**Computers**<br>**£**<br>**£**<br>**Cost**<br>At 1 January 2023<br>529<br>19,140<br>At 31 December 2023<br>529<br>19,140<br>**Depreciation and impairment**<br>At 1 January 2023<br>362<br>7,938<br>Depreciation charged in the year<br>42<br>1,680<br>At 31 December 2023<br>404<br>9,618<br>**Carrying amount**<br>At 31 December 2023<br>125<br>9,522<br>At 31 December 2022<br>167<br>11,202|**Total**<br>**£**<br>19,669|
||19,669|
||8,300<br>1,722|
||10,022|
||9,647|
||11,369|



## **14 Debtors** 

||**2023**|**2022**|
|---|---|---|
|**Amounts falling due within one year:**|**£**|**£**|
|Other debtors|-|2,500|



The above loan was made for charitable purposes in the course of carrying out the charity’s objectives. 

- 16 - 





## ACHEINU CANCER SUPPORT 

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **15 Loans and overdrafts** 

|**Loans and overdrafts**||
|---|---|
|**2023**<br>**£**<br>Bank loans<br>32,084<br>Payable within one year<br>5,000<br>Payable after one year<br>27,084<br>The above long-term loan is guaranteed by the government under the Bounce back loan scheme.|**2022**<br>**£**<br>37,084|
||5,000<br>32,084|
|||



The loan accrues interest at 2.5% p.a. 

## **16 Creditors: amounts falling due within one year** 

|**2023**<br>**Notes**<br>**£**<br>Bank loans<br>**15**<br>5,000<br>Other taxation and social security<br>115<br>Trade creditors<br>6,728<br>Accruals and deferred income<br>4,503<br>16,346<br>**Creditors: amounts falling due after more than one year**<br>**2023**<br>**Notes**<br>**£**<br>Bank loans<br>**15**<br>27,084<br>**Analysis of net assets between funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Total Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**2023**<br>**2023**<br>**2023**<br>**2022**<br>**2022**<br>**£**<br>**£**<br>**£**<br>**£**<br>**£**<br>Fund balances at 31<br>December 2023 are<br>represented by:<br>Tangible assets<br>9,647<br>-<br>9,647<br>11,369<br>-<br>Current assets/(liabilities)<br>125,141<br>43,024<br>168,165<br>52,311<br>82,661<br>Long term liabilities<br>(27,084)<br>-<br>(27,084)<br>(32,084)<br>-<br>107,704<br>43,024<br>150,728<br>31,596<br>82,661|**2022**<br>**£**<br>5,000<br>12<br>7,483<br>5,950|
|---|---|
||18,445|
||**2022**<br>**£**<br>32,084|
||**Total**<br>**2022**<br>**£**<br>11,369<br>134,972<br>(32,084)|
||114,257|



## **17 Creditors: amounts falling due after more than one year** 

## **18 Analysis of net assets between funds** 

- 17 - 





## ACHEINU CANCER SUPPORT 

## NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023 

## **19 Related party transactions** 

During the year the charity made payments of £17,746 for services provided by individuals related to some of the trustees of the charity and £39,000 for goods. After considering all options it was decided that it was in the charity's best interest to go ahead with these transactions and appropriate action was taken to manage any conflicts of interest. 

There were no other disclosable related party transactions during the year (2022 - none). 

|**20**|**Cash generated from operations**||**2023**|**2022**|
|---|---|---|---|---|
||||**£**|**£**|
||Surplus/(deficit) for the year||36,471|(83,827)|
||Adjustments for:||||
||Investment income recognized in statement of financial activities||-|(5,128)|
||Depreciation and impairment of tangible fixed assets||1,722|2,033|
||Movements in working capital:||||
||Decrease in debtors||2,500|94,537|
||(Decrease) in creditors||(2,099)|(15,839)|
||**Cash generated from/(absorbed by) operations**||38,594|(8,224)|
|**21**|**Analysis of changes in net funds**||||
|||**At 1 January**|**Cash flows At**|**31 December**|
|||**2023**||**2023**|
|||**£**|**£**|**£**|
||Cash at bank and in hand|150,917|33,594|184,511|
||Loans falling due within one year|(5,000)|-|(5,000)|
||Loans falling due after more than one year|(32,084)|5,000|(27,084)|
|||113,833|38,594|152,427|



- 18 - 

